Chen DT, Tomohiro MKo Allen AA, Bonnie RJ, Suratt CE, Appelbaum PS, Nunes EV, Friedmann PD, Lee JD, Gordon MS, McDonald R, Wilson D, Boney TY, Murphy SM, and O’Brien CP (in press). Personal control over decisions to participate in research by persons with histories of both substance use disorders and criminal justice supervision. Journal of Empirical Research on Human Research Ethics.
Fletcher JB, Swendeman D, Reback CJ (in press). Associations Between Major Depressive Episode, Methamphetamine Use Disorder Severity, and Engagement in Sexual Risk-Taking Among Methamphetamine-Using Men Who Have Sex with Men. AIDS and Behavior. doi: 10.1007/s10461-017-1974-4. PMID: 29164354.
Gordon MS, Blue TR, Couvillion K, Schwartz RP, O’Grady KE, Fitzgerald TT & Vocci FJ (in press). Impact of Starting Buprenorphine Treatment Prior to vs. After Release from Prison: Arrest Outcomes. Drug and Alcohol Dependence.
Monico LB, Gryczynski J, Schwartz RP, Jaffe JH, O’Grady KE, & Mitchell SG (in press). Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12-months. American Journal of Drug and Alcohol Abuse.
Zhang S, Shoptaw S, Reback CJ, Yadav K and Nyamathi A (in press). Cost-Effective Way to Reduce Stimulant Abuse among Gay/Bisexual Men and Transgender Women: A Randomized Clinical Trial with a Cost Comparison. Public Health.